BCL2, an anti-apoptotic protein, plays a crucial role in the regulation of cell survival, and its expression is often dysregulated in various cancers, contributing to tumorigenesis and the resistance of cancer cells to cell death signals[21,22]. This evidence concerns the gene BCL2 and cancer.